Around 10% of individuals taking ACE inhibitors (ACEI) to control blood pressure will develop a persistent dry cough. This leads to inappropriate antiobiotic use and eventually to discontinuation of the ACEI medication. US investigators in collaboration with PREDICTION ADR have found a common gene variant that identifies individuals more susceptible […]
News
5 posts
PREDICTION-ADR partner Asper Biotech is working on the implementation of new reliable and validated testing panels to predict the side effects of statins and ACE inhibitors. Asper’s new testing portfolio – Asper Cardiogenetics – launched in 2015 – offers among other options risk assessment for developing adverse drug reactions, namely statin-induced myopathy. Currently the validated test […]
The second newsletter of the PREDICTION-ADR consortium has been published. Read about the recent annual plenary meeting of the consortium held in Uppsala where the progress of the research was discussed. PREDICTION-ADR partner ASPER Biotech is now marketing a genetic test which can help predict which patients are likely to suffer […]
The first newsletter of the PREDICTION-ADR consortium has been published. Read about the recent annual plenary meeting of the consortium held in Utrecht where the recent progress of the research was discussed. The PREDICTION-ADR team have also been active in defining the specific phenotypes of statin associated myopathy and ACE […]
Thousands of people with heart disease suffer severe adverse reactions to some of the main drugs – statins and ACE inhibitors – that are used to treat it. Now a new European-wide study led by the University of Dundee is set investigate whether genetic research could be used to predict […]